Learn More
  • Nir Barak
  • Expert opinion on investigational drugs
  • 2008
BACKGROUND Betahistine is an orally administered, centrally acting histamine H(1) receptor agonist with partial H(3) antagonistic activity and no H(2)-binding effects. In the past betahistine was(More)